What is CDP-Choline?
Choline donor and nootropic compound used for cognitive and neuro-support protocols (non-peptide).
Research Indications
Research suggests improvements in memory, focus, and cognitive processing
May protect neurons from oxidative stress and inflammatory damage
Some studies report anxiolytic and mood-stabilizing effects
Research Protocols
These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Starting Dose | Low dose | Once daily | Intranasal or Injectable |
| Standard Dose | Standard | Once daily | Intranasal or Injectable |
Peptide & Drug Interactions
Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.
How to Reconstitute & Inject
Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.
- 1
Remove CDP-Choline vial from refrigeration and allow to reach room temperature (15–20 minutes)
- 2
Clean vial top with alcohol swab and allow to air dry completely
- 3
Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)
- 4
Inject BAC water slowly down the side of the vial — do not aim directly at the powder
- 5
Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide
- 6
Allow 2–3 minutes for full dissolution — solution should be clear and colorless
- 7
Draw calculated dose into an insulin syringe for subcutaneous injection
- 8
Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy
- 9
Store reconstituted solution refrigerated (2–8°C) and use within 28 days
What to Expect
Week 1–2
Subtle mood and focus improvements may begin. Sleep quality often improves early.
Week 2–4
Increased mental clarity, word recall, and reduced brain fog reported by many.
Week 4–8
Consistent cognitive improvements. Better stress response and working memory.
Week 8+
Sustained cognitive and neurological benefits. Effects may persist post-cycle.
Side Effects & Safety
- Headache, particularly at initiation
- Mild anxiety or restlessness with some compounds
- Nasal irritation (intranasal administration)
- Sleep disturbance if dosed too close to bedtime
- Rare: Mood changes or emotional lability
FDA Status & Regulatory Info
Choline donor and nootropic compound used for cognitive and neuro-support protocols (non-peptide).
Frequently Asked Questions
Community-reported data
The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.
What 208 users report
Observational self-reports (modeled when live data is unavailable). Not clinical outcomes.
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 52% · Mixed 36% · Unfavorable overall 12%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Self-reported dose per injection
Median bucket: 0.2–0.4 mg · Most common: 0.1–0.2 mg
Reports span 0.01–2 mg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
Common discussion topics
How repeat users are trending
Among repeat reporters, 62% said they felt similar to their last entry, 32% more positive, and 12% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 15 days · Based on 46 repeat reporters
Share Your Experience
Rate CDP-Choline in the PeptIQ app and help the community make informed decisions.
Research References (4)
Cited PubMed, trial registry, and label sources for education only. We do not control third-party content.
- Wiki study page →Source
PubMed
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
Davalos A, Alvarez-Sabin J, Castillo J, et al. Lancet. 2012
- Wiki study page →Source
PubMed
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)
Zafonte RD, Bagiella E, Ansel BM, et al. JAMA. 2012
- Wiki study page →Source
ClinicalTrials.gov
International Citicoline Trial on Acute Stroke (ICTUS) (NCT00331890)
ClinicalTrials.gov. Clinical trial registry. 2006
- Wiki study page →Source
ClinicalTrials.gov
Citicoline Brain Injury Treatment Trial (COBRIT) (NCT00545662)
ClinicalTrials.gov. Clinical trial registry. 2007
Wiki tools
Observational indexes and compare views for CDP-Choline.
Often tracked with
Educational information only
This page is for educational reference. It is not medical or legal advice. PeptIQ does not sell peptides or list vendors. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.